top of page

Our Achievements

  • ​​Collaborations with Royal United Hospitals Bath, University of Birmingham, Genomics Institute at the University of Birmingham, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford University NDORMS, London School of Hygiene and Tropical Medicine, Kings College London, University of Exeter, University College London, the Alzheimer’s Society, British Heart Foundation, Royal Marsden Hospital and Cancer Research UK. 

​​

  • Commercial partnerships with the global pharmaceutical Bayer, Kinetix, Ovid and Synetic, including winning an internal innovation award in Bayer.​

​​

  • Three published research papers: 

  1. Rheumatology International - in collaboration with the Royal United Hospital for Rheumatic Diseases, focused on Ankylosing Spondylitis.

  2. Nature Publication - in collaboration with Clinical Bioinformatics at the Genomics Institute at the University of Birmingham.  The paper focused on mapping phenotypes discussed by patients within social conversation back to genetics to improve the diagnosis of rare diseases. "Talking about diseases: developing a social media digital phenotype to represent public perspectives on disease." 

  3. Healthcare Publication - in collaboration with the University of Oxford, focused on Fibromyalgia.

  4. We have one further paper in development with University Hospitals Birmingham NHS Trust, focused on Hypertrophic Cardiomyopathy early signs and symptoms with the aim of accelerating diagnosis.

For the full details of our achievements, please see our Trustee reports. These include:

​

 

  • ​Attracting over £1m of funding​

​​

  • Growth of worldwide volunteers from zero to 130

​​

  • Winning a place on the London NHS Accelerator Programme – reaching the final 20 from 169 applicants, for our Million Minds Patient-facing App

​

  • Conducting numerous trainings for pharmaceutical and health care commercial clients on the role social data can play to gain a unique and valuable insight into patients’ experiences, including Learn with Nurses in 2023 and 2024.  

​

  • Achieving a finalist position in 2019 Europe’s Digital Top 50, out of 550 entrant organisations, as judged by Google, McKinsey, Rocket and INSEAD, recognising White Swan’s start-up potential.   Winning an innovation award at Bayer.

​

  • Invited to present, participate in panels to elevate understanding of how social data can be used to improve health including: DigitalHealth AI&Data 2022, Nicholas Hall's CHC European Conference, Pharma Integrates 2023.  Invited to present at IIEX 2024, Digital Rewired 2024 and General Practitioners Division of the Computer Society Conference (2024). 

​

  • Uncovering patient insights across disease areas including oncology, dementia, hypertrophic cardiomyopathy and other cardiology areas, fibromyalgia, ankylosing spondylitis, long covid, mental health, genetic newborn screening, psoriatic arthritis, Parkinson's, central post stroke syndrome, and the prediction of accident and emergency admission rates.

​

  • Development of the Million Minds Discovery Tool for clinicians and researchers, enabling them to access and self-analyse our datasets.  Tool launched in January 2025 and being utilised by multiple university research teams in 2025.

​

  • Creation of proprietary taxonomies across a variety of health areas, including cardiology, oncology, weight loss and motor neurone disease.  Development of proprietary methodologies to leverage the advanced processing of large language models (LLM) capabilities  on our own sourced social data, whilst ensuring high levels of accuracy. Creation of clustering methodologies to segment and define patient needs. 

​

  • Our development of Million Minds as a patient-facing app has reach proof-of-concept stage with diagnostic model including 600 conditions and 6000 symptoms. It has been tested with 140 real patient profiles and 3000 synthetically generated profiles, delivering an 86% accuracy based on the strength of association between symptoms and conditions from both expert knowledge and trends seen within a dataset of 200 million social conversations.​

​

  • Shortlisted for a share of £4m UK Space Agency/NHS/European Space Agency grant to develop an application to meet mental health needs (2019).

​

  • Analysed 44,000 research papers related to Coronavirus, pro-bono, to facilitate work of clinicians and researchers to search for answers during the 2020 pandemic. Following this analysed trends in 5million online conversations relating to Long Covid for a Professor of Clinical Data Science at UCL, to inform future care strategy.​

​

To find out more about the above or any of our work please contact hello@whiteswan.org.uk

iStock-1422478091_edited.jpg

Our work

See how we use technology and analytics to unlock the patient’s voice and improve the health of society

Digital wallet on phone

Case studies

See how Million Minds has helped organisations to improve the health of society

Working at home

Our people

Meet our wonderful team of employees, trustees, volunteers, clinical advisors and friends at Black Swan

bottom of page